Want access to these reports and real time alerts? Go to www.tradethetrend.com now for a FREE two-week trial.

Write to Chip Brian at cbrian@tradethetrend.com

---------------------------------------------------------------------------------------------

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html

Increasing regulatory mandates and oversight in the healthcare industry is compelling companies to streamline and synergize processes related to policy and procedure management, compliance management, risk management, internal audits, quality of services and operations, incident tracking, corrective action plans and regulatory reporting. By adopting MetricStream as the technology infrastructure, Amedisys will be able to continue to automate the reporting of its risk and compliance information.

"We wanted to further automate the accumulation and reporting of information by our risk and compliance groups and we believe that MetricStream best meets our needs," said Collin McQuiddy, Vice President of Enterprise Risk Management at Amedisys.

"We are pleased to have Amedisys as a customer and look forward to working with them towards their goal of bringing additional automation to their risk (http://www.metricstream.com/solutions/risk_management.htm) and compliance (http://www.metricstream.com/products/compliance_management.htm) efforts," said Gaurav Kapoor, CFO and General Management at MetricStream. "The selection by Amedisys of MetricStream illustrates our continued leadership in GRC and the compelling value we deliver for healthcare companies."

About MetricStream MetricStream is a market leader in Enterprise-wide Governance, Risk, Compliance (http://www.metricstream.com/solutions/solutions.htm) ("GRC") and Quality Solutions for global corporations. MetricStream solutions are used by leading corporations such as Pfizer, Philips, NASDAQ, UBS, SanDisk, BP, Subway, Fairchild Semiconductor, Hitachi and TaylorMade-Adidas Golf in diverse industries such as Pharmaceuticals, Medical Devices, Automotive, Food, High Tech Manufacturing, Energy and Financial Services to manage their quality processes, regulatory and industry-mandated compliance and corporate governance initiatives, as well as by over a million compliance professionals worldwide via the www.ComplianceOnline.com portal. MetricStream is headquartered in Palo Alto, California and can be reached at metricstream.com (http://www.metricstream.com).

Media contact: pr (at) metricstream (dot) com

###

Read the full story at http://www.prweb.com/releases/2009/11/prweb3197454.htm.

PRWeb.com

"We are pleased with the results that Marwood found in their review of our Company," stated William F. Borne, Chief Executive Officer. "We operate our Company with a view toward providing clinical excellence for our patients while maintaining effective compliance and controls, and these findings evidence our leadership in these and other measures."

Marwood Group Advisory, LLC and its affiliated companies (Member FINRA and SIPC) is a nationally recognized healthcare advisory and financial services firm headquartered in New York City with additional offices in Washington DC and London. Marwood has over 90 employees including former senior White House staff, federal agency leaders (including CMS, FDA, HHS and AHRQ) and congressional committee staff members as well as former senior healthcare operators from health plans and hospitals, former employees of state agencies, and former management consultants who monitor and analyze issues related to healthcare. Marwood provides specialized analysis for corporations, financial sponsors and other investors looking to evaluate the regulatory and reimbursement framework and risks associated with making direct investments in healthcare services, life sciences, and devices.

Amedisys, Inc. is headquartered in Baton Rouge, Louisiana. Its common stock trades on the NASDAQ Global Select Market under the symbol "AMED."

This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe", "estimate", "project", "expect", "anticipate" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Many of the factors that could cause or contribute to such differences are described in the Company's periodic reports and registrations statements filed with the Securities and Exchange Commission, and include, but are not limited to the following: general economic and business conditions, changes in or failure to comply with existing regulations or the inability to comply with new government regulations on a timely basis, changes in Medicare and other medical reimbursement levels, ability to complete acquisitions announced from time to time, and any financing related thereto, the ability to meet debt service requirements and to comply with covenants in debt agreements, adverse changes in federal and state laws relating to the health care industry, demographic changes, availability and terms of capital, ability to attract and retain qualified personnel, ongoing development and success of new start-ups, ability to successfully integrate newly acquired agencies, changes in estimates and judgments associated with critical accounting policies, business disruption due to natural disasters or acts of terrorism, and various other matters, many of which are beyond management's control. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.

Our company website address is www.amedisys.com. We use our website as a channel of distribution for important company information. Important information, including press releases, analyst presentations and financial information regarding the Company is routinely posted on and accessible on the "Investor Relations" subpage of our website, which is accessible by clicking on the tab labeled "Investors" on our website home page. We will also use our website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the Securities and Exchange Commission ("SEC") disclosing the same information. In addition, we make available on the Investor Relations subpage of our website (under the link "SEC filings") free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation and Nominating and Governance Committees of our Board are also available on the Investor Relations subpage of our website (under the link "Corporate Governance").

Additional information on the Company can be found at: www.amedisys.com

SOURCE: Amedisys, Inc.

Amedisys, Inc. 
Kevin B. LeBlanc, 225-292-2031 
Director of Investor Relations 
kleblanc@amedisys.com

"We are very excited about this opportunity," said William F. Borne, Chief Executive Officer of Amedisys, Inc. "This will be our initial entrance into New Jersey, a state with substantial demographics. Combined, the two counties served by this agency have approximately 1.5 million in total population and more than 200,000 people over the age of 65. We look forward to building on the excellent care and service the agency currently provides to the patients in this community by introducing Amedisys clinical programs, providing additional financial and operational resources, and expanding business development efforts."

((Comments on this story may be sent to health@closeupmedia.com))